- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05313737
Opt-in vs. Opt-out for Breast Cancer Screening
Opt-in vs. Opt-out Mammography Screening Outreach: a Randomized Controlled Trial
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This is a prospective, randomized controlled trial that will evaluate the effectiveness of two different outreach strategies in improving adherence to breast cancer screening via mammography.
Average risk female Veterans who are due for breast cancer screening (defined as aged 45-75 with no previous history of bilateral mastectomy, not under hospice care, and alive at the time of screening) will be identified through administrative data.
Veterans eligible for enrollment into the trial will be randomized in a 1:1 allocation using permuted block randomization (with random block sizes of 2 and 4) to the following interventions:
Arm 1: Automated phone opt-in message Intervention Type: Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent Arm 2: Opt-out scheduling Intervention Type: Consult automatically sent and Veteran called to schedule screening
Randomization will be stratified within arms by prior screening status (prior screener vs. never screener).
The study's primary outcome of interest is screening completion at 100 days post randomization. The study's secondary outcome of interest is screening scheduling at 100 days post randomization. Subgroup analysis aim 1 will explore whether the differences in breast cancer screening completion between investigational groups varies according to the Veterans' race/ethnicity. Subgroup analysis aim 2 will explore whether the differences in breast cancer screening scheduling between investigational groups varies according to the Veterans' race/ethnicity. Enrollment in the trial will occur between March 1, 2022 and August 31, 2022.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Stefanie Deeds, MD
- Telefonnummer: 206-314-0507
- E-post: Stefanie.Deeds@va.gov
Studera Kontakt Backup
- Namn: Alaina Mori, MS
- Telefonnummer: 206-247-6782
- E-post: Alaina.Mori@va.gov
Studieorter
-
-
Washington
-
Seattle, Washington, Förenta staterna, 98108
- VA Puget Sound Health Care System
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- female Veterans aged 45-75
- assigned to a primary care provider at the VA Puget Sound as of January 1, 2022 with at least 1 year of prior data available
- due for breast cancer screening (have not had a mammogram in the last 12 months)
Exclusion Criteria:
- must not be any indication of current receipt of hospice care
- no record of recent death in the administrative data
- not scheduled for either a screening or diagnostic mammogram within the following 12 weeks from assessment.
- not have a personal history of bilateral mastectomy.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Undersökning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Automated phone opt-in message
Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent
|
Automated message via phone call (audiocare)
|
|
Experimentell: Opt-out scheduling
Consult automatically sent and Veteran called to schedule screening
|
Scheduling via non-automated phone call
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Percentage of mammograms completed at 100 days post randomization
Tidsram: 100 days post randomization
|
Percent of mammograms completed
|
100 days post randomization
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Percentage of mammograms scheduled at 100 days post randomization
Tidsram: 100 days post randomization
|
Percent of mammograms scheduled
|
100 days post randomization
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Percentage of mammograms cancelled at 100 days post randomization
Tidsram: 100 days post randomization
|
Percent of mammograms cancelled
|
100 days post randomization
|
|
Percentage of mammograms active at 100 days post randomization
Tidsram: 100 days post randomization
|
Percent of mammograms active
|
100 days post randomization
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Ashok Reddy, MD, VA Puget Sound Health Care System
- Huvudutredare: Stefanie Deeds, MD, VA Puget Sound Health Care System
Studieavstämningsdatum
Studera stora datum
Studiestart (Förväntat)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MAMMoutreach
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .